Gastrointestinal tissue repair supporting the recovery of the gut lining and stomach tissue in experimental models*
Gwak, H
Since treatments are minimally invasive and work at the cellular level, side effects are rare and typically mild (e.g., temporary redness at the injection site)
Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production
The expression levels of cross-linking enzymes and structural proteins produced by cellssuch as keratin laminin, filaggrin (FLG), transglutaminase-1, and keratin filamentthat are related to skin barrier function are downregulated under the action of ROS, thereby impairing skin barrier function ( FIGURE 5 4 Therapeutic strategies based on ROS regulation With the deepening understanding of the role of ROS in skin diseases, various therapeutic strategies targeting ROS regulation have been developed
This synthetic peptide mimics Thymosin Beta-4, a natural powerhouse found in nearly all cells
